Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

• Main Authors: Sergey V Efimov (Author), Natallia V Matsiyeuskaya (Author), Olga V Boytsova (Author), Lyudmila Yu Akhieva (Author), Elena I Kvasova (Author), Francisco Harrison (Author), Yulia S Karpova (Author), Anton Tikhonov (Author), Nadezhda F Khomyakova (Author), Tim Hardman (Author), Jean-François Rossi (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The authors wish to make the following corrections to their article: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study....